American Journal of Clinical Pathology · 2000 · 22 citations · 9 references
MedicineHematologyImmunologyClinical ImmunologyTransfusion MedicineTransplant ImmunologyGraft-versus-host DiseaseHistocompatibilityRed Blood Cell TransfusionTransfusion ReactionsTransfusion SupportTransfusion TherapyBlood Product IrradiationDonor-recipient Immune CompatibilityMassive Gastrointestinal HemorrhageMultiplex Polymerase Chain Reaction (Pcr)Multiplex Polymerase Chain Reaction AssaysTransfusion-associated Graft-versus-host DiseaseTransfusion-related ComplicationsUnrelated Donation
Transfusion-associated graft-vs-host disease (TA-GVHD) is a rare complication of transfusion. We report fatal TA-GVHD in a 63-year-old coronary artery bypass patient of European descent after an RBC transfusion from an unrelated donor. The patient had mild lymphocytopenia and received 2 80-mg doses of methylprednisolone and 7 units of RBCs. On day 14 after the transfusion, he had fever, elevated liver enzyme levels, and a macular rash. Pancytopenia and bone marrow aplasia developed. On day 26, he had a massive gastrointestinal hemorrhage and died. At autopsy, histopathologic findings of the skin, liver, bone marrow, and gastrointestinal tract were consistent with TA-GVHD. One donor of the transfused RBCs (3 days old at transfusion) had a 1-way HLA match with the patient. A method using multiplex polymerase chain reaction is presented. This patient with TA-GVHD and mild immune suppression suggests that blood component irradiation guidelines may need to be reevaluated.
9
M Akahoshi, Minoko Takanashi, M Masuda et al. · Transfusion · 1992 · 165 citations
Medicine, Hematology, Oncology +15